61 related articles for article (PubMed ID: 16808915)
1. Matrix metalloproteinases--a conceptional alternative for disease-modifying strategies in ALS/MND?
Ludolph AC
Exp Neurol; 2006 Oct; 201(2):277-80. PubMed ID: 16808915
[No Abstract] [Full Text] [Related]
2. Lack of apoptosis in mice with ALS.
Migheli A; Atzori C; Piva R; Tortarolo M; Girelli M; Schiffer D; Bendotti C
Nat Med; 1999 Sep; 5(9):966-7. PubMed ID: 10470053
[No Abstract] [Full Text] [Related]
3. The matrix metalloproteinases inhibitor Ro 28-2653 [correction of Ro 26-2853] extends survival in transgenic ALS mice.
Lorenzl S; Narr S; Angele B; Krell HW; Gregorio J; Kiaei M; Pfister HW; Beal MF
Exp Neurol; 2006 Jul; 200(1):166-71. PubMed ID: 16516196
[TBL] [Abstract][Full Text] [Related]
4. Superoxide dismutase and neurofilament transgenic models of amyotrophic lateral sclerosis.
Morrison BM; Morrison JH; Gordon JW
J Exp Zool; 1998 Sep-Oct 1; 282(1-2):32-47. PubMed ID: 9723164
[TBL] [Abstract][Full Text] [Related]
5. Partial deficiency of manganese superoxide dismutase exacerbates a transgenic mouse model of amyotrophic lateral sclerosis.
Andreassen OA; Ferrante RJ; Klivenyi P; Klein AM; Shinobu LA; Epstein CJ; Beal MF
Ann Neurol; 2000 Apr; 47(4):447-55. PubMed ID: 10762155
[TBL] [Abstract][Full Text] [Related]
6. Human Cu/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacuolization, axonal degeneration, and premature motoneuron death and accelerates motoneuron disease in mice expressing a familial amyotrophic lateral sclerosis mutant SOD1.
Jaarsma D; Haasdijk ED; Grashorn JA; Hawkins R; van Duijn W; Verspaget HW; London J; Holstege JC
Neurobiol Dis; 2000 Dec; 7(6 Pt B):623-43. PubMed ID: 11114261
[TBL] [Abstract][Full Text] [Related]
7. Superoxide dismutase: the cause of all amyotrophic lateral sclerosis?
Matias-Guiu J; Galan L; Garcia-Ramos R; Barcia JA
Ann Neurol; 2008 Sep; 64(3):356-7; author reply 358. PubMed ID: 18350588
[No Abstract] [Full Text] [Related]
8. Amyotrophic lateral sclerosis: recent insights from genetics and transgenic mice.
Brown RH
Cell; 1995 Mar; 80(5):687-92. PubMed ID: 7889564
[No Abstract] [Full Text] [Related]
9. In vivo quantification of spinal and bulbar motor neuron degeneration in the G93A-SOD1 transgenic mouse model of ALS by T2 relaxation time and apparent diffusion coefficient.
Niessen HG; Angenstein F; Sander K; Kunz WS; Teuchert M; Ludolph AC; Heinze HJ; Scheich H; Vielhaber S
Exp Neurol; 2006 Oct; 201(2):293-300. PubMed ID: 16740261
[TBL] [Abstract][Full Text] [Related]
10. Activation of the stress-activated MAP kinase, p38, but not JNK in cortical motor neurons during early presymptomatic stages of amyotrophic lateral sclerosis in transgenic mice.
Holasek SS; Wengenack TM; Kandimalla KK; Montano C; Gregor DM; Curran GL; Poduslo JF
Brain Res; 2005 May; 1045(1-2):185-98. PubMed ID: 15910777
[TBL] [Abstract][Full Text] [Related]
11. Superoxide dismutase may lead to cytoskeletal abnormalities and amyotrophic lateral sclerosis.
Brenner S
Ann Neurol; 2008 Sep; 64(3):357-8; author reply 358. PubMed ID: 18409199
[No Abstract] [Full Text] [Related]
12. What have cellular models taught us about ALS?
Shaw C
Amyotroph Lateral Scler Other Motor Neuron Disord; 2002 Jun; 3(2):55-6. PubMed ID: 12215225
[No Abstract] [Full Text] [Related]
13. Calcium-permeable AMPA receptors promote misfolding of mutant SOD1 protein and development of amyotrophic lateral sclerosis in a transgenic mouse model.
Tateno M; Sadakata H; Tanaka M; Itohara S; Shin RM; Miura M; Masuda M; Aosaki T; Urushitani M; Misawa H; Takahashi R
Hum Mol Genet; 2004 Oct; 13(19):2183-96. PubMed ID: 15294873
[TBL] [Abstract][Full Text] [Related]
14. Metallothionein expression is altered in a transgenic murine model of familial amyotrophic lateral sclerosis.
Gong YH; Elliott JL
Exp Neurol; 2000 Mar; 162(1):27-36. PubMed ID: 10716886
[TBL] [Abstract][Full Text] [Related]
15. Neurobiology. Stay the executioner's hand.
Gurney ME; Tomasselli AG; Heinrikson RL
Science; 2000 Apr; 288(5464):283-4. PubMed ID: 10777410
[No Abstract] [Full Text] [Related]
16. Determinants of rapid disease progression in ALS.
Yamanaka K; Cleveland DW
Neurology; 2005 Dec; 65(12):1859-60. PubMed ID: 16380607
[No Abstract] [Full Text] [Related]
17. Motor neuron disease in mice expressing the wild type-like D90A mutant superoxide dismutase-1.
Jonsson PA; Graffmo KS; Brännström T; Nilsson P; Andersen PM; Marklund SL
J Neuropathol Exp Neurol; 2006 Dec; 65(12):1126-36. PubMed ID: 17146286
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of p38 mitogen activated protein kinase activation and mutant SOD1(G93A)-induced motor neuron death.
Dewil M; dela Cruz VF; Van Den Bosch L; Robberecht W
Neurobiol Dis; 2007 May; 26(2):332-41. PubMed ID: 17346981
[TBL] [Abstract][Full Text] [Related]
19. Coincident thresholds of mutant protein for paralytic disease and protein aggregation caused by restrictively expressed superoxide dismutase cDNA.
Wang J; Xu G; Slunt HH; Gonzales V; Coonfield M; Fromholt D; Copeland NG; Jenkins NA; Borchelt DR
Neurobiol Dis; 2005 Dec; 20(3):943-52. PubMed ID: 16046140
[TBL] [Abstract][Full Text] [Related]
20. Oxidative stress, mutant SOD1, and neurofilament pathology in transgenic mouse models of human motor neuron disease.
Tu PH; Gurney ME; Julien JP; Lee VM; Trojanowski JQ
Lab Invest; 1997 Apr; 76(4):441-56. PubMed ID: 9111507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
